Boehringer Ingelheim
Eric Block possesses extensive experience in oncology clinical development and medical affairs, currently serving as Clinical Program Lead at Boehringer Ingelheim since February 2015. Previous roles at Boehringer Ingelheim include Senior Associate Director and Associate Director in the field of oncology. Eric Block also held the position of Medical Science Liaison at Saladax Biomedical and held various roles, including Medical Director, at Grey Healthcare Group. Academic credentials include a PhD in Biomedical Sciences from New York University School of Medicine, with a focus on molecular oncology and immunology, and a BS in Biochemistry from Brown University.
This person is not in the org chart
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.